{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:07:24Z","timestamp":1777396044356,"version":"3.51.4"},"reference-count":30,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2018,7,3]]},"DOI":"10.3233\/jad-180306","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T15:06:41Z","timestamp":1530025601000},"page":"899-910","source":"Crossref","is-referenced-by-count":3,"title":["Real-World, Multinational, Retrospective Observational Survey of the ADAS-Cog and Associations with Healthcare Resource Utilization in Patients with Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"64","author":[{"given":"Craig W.","family":"Ritchie","sequence":"first","affiliation":[{"name":"Centre for Dementia Prevention, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rezaul K.","family":"Khandker","sequence":"additional","affiliation":[{"name":"Center for Observational and Real-World Evidence, Merck & Co., Inc., Kenilworth, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Pike","sequence":"additional","affiliation":[{"name":"Adelphi Real World, Macclesfield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher M.","family":"Black","sequence":"additional","affiliation":[{"name":"Center for Observational and Real-World Evidence, Merck & Co., Inc., Kenilworth, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eddie","family":"Jones","sequence":"additional","affiliation":[{"name":"Adelphi Real World, Macclesfield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baishali M.","family":"Ambegaonkar","sequence":"additional","affiliation":[{"name":"Center for Observational and Real-World Evidence, Merck & Co., Inc., Kenilworth, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-180306_ref2","doi-asserted-by":"crossref","unstructured":"GBD 2015 Disease and Injury Incidence and Prevalence Collaborators (2016) Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet 388, 1545-1602.","DOI":"10.1016\/S0140-6736(16)31678-6"},{"key":"10.3233\/JAD-180306_ref4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/bmj.b158","article-title":"Alzheimer\u2019s disease.","volume":"338","author":"Burns","year":"2009","journal-title":"BMJ"},{"key":"10.3233\/JAD-180306_ref5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1474-4422(16)00062-4","article-title":"Defeating Alzheimer\u2019s disease and other dementias: A priority for European science and society","volume":"15","author":"Winblad","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-180306_ref6","first-page":"4801","article-title":"Cholinesterase inhibitors and non-steroidal anti-inflammatory drugs as Alzheimer\u2019s disease therapies: An updated umbrella review of systematic reviews and meta-analyses","volume":"20","author":"Wang","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.3233\/JAD-180306_ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2012.11.006","article-title":"The worldwide economic impact of dementia 2010","volume":"9","author":"Wimo","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180306_ref8","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMsa1204629","article-title":"Monetary costs of dementia in the United States","volume":"368","author":"Hurd","year":"2013","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-180306_ref9","doi-asserted-by":"crossref","first-page":"A759","DOI":"10.1016\/j.jval.2015.09.2479","article-title":"Comparing resource use in Alzheimer\u2019s disease across three European countries \u2013 18-month results of the GERAS study.","volume":"18","author":"Belger","year":"2015","journal-title":"Value Health"},{"key":"10.3233\/JAD-180306_ref10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/JAD-122392","article-title":"The GERAS study: Aprospective observational study of costs and resource use incommunity dwellers with Alzheimer\u2019s disease in three European countries \u2013 study design and ine findings","volume":"36","author":"Wimo","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180306_ref11","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer\u2019s disease","volume":"141","author":"Rosen","year":"1984","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-180306_ref12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1017\/S1041610297004298","article-title":"Alzheimer\u2019s disease assessment scale: Reliability and validity in a multicenter clinical trial","volume":"9","author":"Weyer","year":"1997","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-180306_ref13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JAD-2008-15312","article-title":"Administration and scoring variance on the ADAS-Cog","volume":"15","author":"Connor","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180306_ref14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2377-7-26","article-title":"The clinical meaningfulness of ADAS-Cog changes in Alzheimer\u2019s disease patients treated with donepezil in an open-label trial","volume":"7","author":"Rockwood","year":"2007","journal-title":"BMC Neurol"},{"key":"10.3233\/JAD-180306_ref15","unstructured":"Moise P , Schwarzinger M , Um M-Y ; Dementia Experts\u2019 Group (2004) Dementia care in 9 OECD countries: A comparative analysis. OECD 2004. https:\/\/www.oecd.org\/els\/health-systems\/33661491.pdf. Accessed on August 18 2017."},{"key":"10.3233\/JAD-180306_ref16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2190\/GCVN-D2LJ-APH3-KN0K","article-title":"Comon of two cognitive rating scales in medically ill patients","volume":"17","author":"Burch","year":"1987","journal-title":"Int J Psychiatry Med"},{"key":"10.3233\/JAD-180306_ref17","first-page":"255","article-title":"P1-266: Disease progression analysis of ADAS-Cog from ADNI database in normal elderly, mild cognitive impairment and Alzheimer\u2019s disease patients.","volume":"5","author":"Ito","year":"2009","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180306_ref18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/nrc.20032","article-title":"ADAS-Cog and mental deterioration battery: Different instruments for different aspects of cognitive decline in Alzheimer\u2019s disease","volume":"35","author":"Serra","year":"2004","journal-title":"Neurosci Res Commun"},{"key":"10.3233\/JAD-180306_ref19","doi-asserted-by":"crossref","first-page":"0138866","DOI":"10.1371\/journal.pone.0138866","article-title":"Predicting progression from mild cognitive impairment to Alzheimer\u2019s dementia using clinical, MRI, and plasma biomarkers via probabilistic pattern classification.","volume":"11","author":"Korolev","year":"2016","journal-title":"PLoS One"},{"key":"10.3233\/JAD-180306_ref20","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10198-011-0334-y","article-title":"Disease progression and costs of care in Alzheimer\u2019s disease patients treated with donepezil: A longitudinal naturalistic cohort","volume":"13","author":"Gustavsson","year":"2012","journal-title":"Eur J Health Econ"},{"key":"10.3233\/JAD-180306_ref21","unstructured":"StataCorp (2017) Stata Statistical Software: Release 15. StataCorp LLC, College Station, TX."},{"key":"10.3233\/JAD-180306_ref22","first-page":"255","article-title":"P1-265: A disease progression meta-analysis model for cognitive deterioration in patients with Alzheimer\u2019s disease.","volume":"5","author":"Ito","year":"2009","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180306_ref23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000152911","article-title":"Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting.","volume":"26","author":"Wattmo","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-180306_ref24","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1176\/ajp.151.3.390","article-title":"A longitudinal study of Alzheimer\u2019s disease: Measurement, rate, and predictors of cognitive deterioration","volume":"151","author":"Stern","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-180306_ref25","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s12603-013-0368-1","article-title":"Association between illness progression measures and total cost in Alzheimer\u2019s disease","volume":"17","author":"Lacey","year":"2013","journal-title":"J Nutr Health Aging"},{"key":"10.3233\/JAD-180306_ref26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2165\/00019053-200927050-00004","article-title":"The cost of dementia in Europe: A review of the evidence, and methodological considerations","volume":"27","author":"J\u00f6nsson","year":"2009","journal-title":"Pharmacoeconomics"},{"key":"10.3233\/JAD-180306_ref27","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1017\/S1041610214002063","article-title":"Longitudinal costs of caring for people with Alzheimer\u2019s disease","volume":"27","author":"Gillespie","year":"2015","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-180306_ref28","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jval.2012.02.003","article-title":"Exploring the relationship between Alzheimer\u2019s disease severity and longitudinal costs","volume":"15","author":"Rapp","year":"2012","journal-title":"Value Health"},{"key":"10.3233\/JAD-180306_ref29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.trci.2015.03.001","article-title":"Using ine cognitive severity for enriching Alzheimer\u2019s disease clinical trials: How does Mini-Mental State Examination predict rate of change?","volume":"1","author":"Kennedy","year":"2015","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-180306_ref30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13195-015-0151-0","article-title":"New scoring methodology improves the sensitivity of the Alzheimer\u2019s Disease Assessment Scale-Cognitive subscale (ADAS-Cog) in clinical trials","volume":"7","author":"Verma","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-180306_ref31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/13825585.2015.1127320","article-title":"Examining the reliability of ADAS-Cog change scores","volume":"23","author":"Grochowalski","year":"2016","journal-title":"Neuropsychol Dev Cogn B Aging Neuropsychol Cogn"},{"key":"10.3233\/JAD-180306_ref32","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1007\/s11095-014-1315-5","article-title":"Improved utilization of ADAS-cog assessment data through item response theory based pharmacometric modeling.","volume":"31","author":"Ueckert","year":"2014","journal-title":"Pharm Res"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-180306","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:25Z","timestamp":1777370845000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-180306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,3]]},"references-count":30,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-180306","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,3]]}}}